← Back to all trials
Completed
NCT05674435
Clinical Utility of Neuromodulation on Tinnitus
Conditions: Tinnitus
Sex: All
Ages: 18 Years – 65 Years
Enrollment: 26
Sponsor: Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan
Location: Taiwan
Summary
The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus.
Our method involves conducting a systemic review and the findings reported following PRISMA statement.
Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients.
Each article was evaluated using the Cochrane risk of bias tool.
Eligibility Criteria
Inclusion Criteria:Tinnitus patientsAt least one of the neurofeedback methodsSingle and multi-centerRandomized control trials and observational studiesExclusion Criteria:Non-peer-reviewed papers, letters, editorialsNot English language
Source: ClinicalTrials.gov (NCT05674435). StuddyBuddy aggregates publicly available trial information.